Hormel (HRL) Q2 2026 Earnings Call Transcript

Hormel Foods delivered a strong Q2 with organic net sales up 3%, adjusted EPS up 14% to $0.40, and gross margin expanding 70 bps to 17.4%. Management reaffirmed full-year guidance for organic sales of $12.2 billion-$12.5 billion and adjusted EPS of $1.43-$1.51, while noting Q3 earnings should be roughly flat year over year due to higher fuel, logistics, and inventory rebalancing costs. The company also completed the whole-bird turkey divestiture and returned $161 million to shareholders via dividends.

Analysis

HRL’s quarter reads as a classic “better business, temporary optics” setup: the core engine is improving while reported cadence gets muddied by portfolio cleanup, inventory normalization, and an unfavorable cost phasing into the next quarter. The important second-order effect is that management is deliberately accepting near-term margin noise to reduce volatility and improve throughput discipline, which should make the earnings base more durable into FY27 even if FY26 looks lumpy.

The winners here are the channels and brands tied to branded protein and foodservice innovation; the losers are lower-velocity ambient and snack subcategories that are being de-emphasized or reallocated. That matters because it suggests HRL is shifting mix away from price-sensitive, commodity-linked shelf space toward higher-return, more defensible niches, which should gradually improve trade efficiency and retailer economics. Competitively, that puts pressure on private-label and weaker nut/snack franchises, while premium protein peers may see a healthier category backdrop rather than a zero-sum share war.

The market likely underappreciates how much of the near-term headwind is timing rather than deterioration. If fuel and logistics stabilize even modestly into Q4, and if the plant-utilization hit is indeed mostly a Q3 event, EPS momentum can re-accelerate quickly off a lower base. The real risk is not this quarter’s guide shape; it is that retail brand fixes take longer than expected and the consumer trade-down environment keeps squeezing premium snack mix longer than the company’s current assumptions.

Contrarian view: this is less about a turnaround and more about a re-rating of execution credibility. The stock may not need heroic volume growth to work — if management keeps converting mix, pricing discipline, and supply-chain productivity into steady margin expansion, HRL can compound in a low-beta defensive way. The consensus is probably too focused on the Q3 step-down and not focused enough on the fact that the company is building a more resilient earnings model beneath it.

Key Decisions for Investors

• Long HRL on a 3-6 month horizon into the expected Q3 trough; thesis is that the market is over-discounting temporary cost and utilization noise. Risk/reward is favorable if Q4 margin reacceleration becomes visible, with downside limited by dividend support and balance-sheet strength.
• Pair trade: long HRL / short a higher-cost packaged-food peer with weaker pricing power and noisier margin cadence over the next 1-2 quarters. The relative trade should benefit if investors reward execution consistency over headline growth.
• Buy HRL call spreads 2-4 months out, struck around the upper end of the current valuation band, to express the view that Q4 earnings normalization will be re-rated before FY27 numbers are visible. Keep sizing modest given Q3 timing risk.
• If already long, add on any post-earnings weakness caused by the Q3 guide rather than the full-year reaffirmation. The best entry is likely after the market digests the temporary margin reset, not on strength.
• Avoid shorting the name here unless freight/fuel materially re-accelerate again; the dividend, cash balance, and portfolio simplification create a strong carry floor that makes outright short risk/reward unattractive.